查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844182

血管闭合装置市场按产品类型、手术类型、接入点、最终用户和分销管道划分 - 全球预测 2025-2032

Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年血管闭合装置市场将成长至 31.1 亿美元，复合年增长率为 7.73%。

主要市场统计数据
基准年2024年 17.1亿美元
预计2025年 18.5亿美元
预测年份：2032年 31.1亿美元
复合年增长率（%） 7.73%

权威介绍，阐述重塑血管闭合装置选择的临床重点、监管压力和程序趋势

血管闭合装置处于临床需求、手术效率和器械创新的交会点。过去十年，临床医生和医院管理人员优先考虑能够缩短止血时间、降低併发症发生率、提高患者周转率且不影响手术安全的解决方案。为此，技术开发人员推出了各种机械和生物学方法，旨在解决穿刺部位的挑战，并与各种手术流程整合。

监管途径、报销压力以及日益以结果主导的采购环境持续影响着设备的开发和应用。随着医疗机构寻求显着缩短住院时间和减少术后併发症，临床证据和实际表现数据正成为采购决策的关键因素。同时，诸如桡动脉入路的扩展以及低风险干预措施向门诊转移等手术趋势正在重新定义临床需求和用例。

综上所述，这些因素共同创造了一个动态的环境，在易用性、安全性以及与微创方法相容性方面的逐步改进，有可能带来显着的临床和操作效益。本引言确立了本摘要其余部分探讨的核心主题：技术差异化、程序一致性、监管考虑因素以及医疗服务提供者和付款人不断变化的需求。

临床、设备创新和采购动态的重大转型正在重新定义血管闭合设备格局

在临床发展、技术进步和医疗服务模式调整的推动下，血管闭合器材的市场格局正经历数次变革。首先，临床上明显倾向于使用能够促进早期活动和减少穿刺部位併发症的器械，从而提高了安全性和易用性的标准。临床医生越来越青睐那些能够最大程度缩短手动按压时间并适应当日出院流程的解决方案，尤其是在门诊病人和门诊环境中。

其次，器械创新正从单纯的机械解决方案转向混合生物活性方法，旨在促进止血并限制异物反应。这一趋势包括改进缝合闭合技术、开发具有优化生物整合的可吸收栓塞，以及即使在具有挑战性的血流动力学条件下也能有效黏附的密封剂。同时，製造商正致力于提高可用性，包括符合人体工学的输送系统、简化的培训工作流程和清晰的操作指南，以减少临床结果的差异性。

第三，医疗保健采购的结构性动态正在改变打入市场策略。医院系统和门诊手术中心正在整合其采购框架，并要求提供可靠的真实世界证据和上市后监测数据。这些变化要求製造商制定全面的价值主张，将临床结果与营运效益和资源利用率连结起来。因此，设备製造商、临床领导者和医疗系统之间的策略合作正成为实现应用的关键途径。

2025 年美国关税如何改变整个医疗设备价值链的供应链策略、产品优先顺序和定价动态

2025年美国关税的实施对整个供应链产生了显着影响，影响了设备製造商的零件采购、製造策略和定价动态。对某些进口材料和次组件的关税促使企业重新评估其供应商布局，加速关键零件的近岸外包，在某些情况下，甚至重新设计其供应链，以降低关税上调带来的风险。这些商业反应对于先前依赖单一来源进口精密聚合物、生物製药原料和特殊供应零件的企业尤其明显。

同时，关税带来的成本压力促使一些製造商重新评估产品系列，优先投资利润率更高的差异化技术，而非商品化产品。这种转变也影响了竞争定位，供应链弹性较低的小型企业面临利润率压缩，而大型企业则利用其规模来吸收或抵消不断上涨的关税。此外，医疗系统采购团队正在透过更严格的成本效益分析来应对下游价格调整，不仅关注单位成本，还关注医疗总成本和供应商可靠性。

最后，监管和贸易的不确定性再次引发了对库存韧性和合约保障的关注。企业越来越多地与供应商协商长期合同，实现供应商多元化，并投资于供应链视觉化工具，以预测和应对与关税相关的中断。因此，2025年的关税环境引发了製造、采购和商业营运领域的策略调整。

细分主导的洞察揭示了产品设计、程序环境、访问站点动态、最终用户需求和通路如何影响采用模式

对细分市场的细緻考察揭示了临床需求与产品功能和商业管道的交汇点。对于胶原蛋白塞，牛蛋白塞和合成胶原蛋白蛋白塞之间的区别会影响临床医生基于生物相容性和吸收特性的偏好，而封闭剂的选择（例如几丁聚醣封闭剂与聚乙二醇封闭剂）则反映了粘合强度和炎症潜能之间的权衡。这些产品层面的差异不仅影响临床选择，还会影响培训需求和库存规划。

从手术类型来看，诊断性手术包括血管造影术手术和血流动力学监测，其中快速止血和尽量减少对血管造影的干扰至关重要；而介入性手术包括介入心臟病学和外周介入，这些手术需要在使用大口径鞘套的情况下进行高抗凝血和可靠的闭合。入路部位——股动脉还是桡动脉——仍然是决定设备相关性的关键因素，其中桡动脉入路推动了对低调、易于使用的系统的需求，而股动脉入路则维持了对坚固的机械闭合方案的需求。

终端使用场景（门诊手术中心、诊所和医院）的差异决定了购买行为和设备采用时间表。门诊手术中心优先考虑吞吐量和易用性，而医院则强调全面的临床证据和多操作员适用性。销售管道动态直接分销商和第三方经销商，直接分销商提供更紧密的临床培训和价值主张一致性，而第三方经销商提供广泛且覆盖异质基本客群的服务。这些细分层次共同促成了有针对性的产品开发和差异化的市场策略。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和战略影响将影响每种市场方法

区域动态对临床偏好、监管方法和商业策略有重大影响。美洲的临床实务模式具有以下特点：广泛采用桡动脉和股动脉入路技术，先进的报销模式日益重视效率，以及大型综合医疗体系的集中，这些体系在获得确凿证据支持的情况下可以加速创新的采用。供应链的接近性和国内製造能力也在采购决策中发挥作用，影响企业在该地区建立分销和服务模式的方式。

在欧洲、中东和非洲，法规环境差异化和医疗服务提供环境多样化，为市场参与企业带来了挑战和机会。各国的保险报销结构差异庞大，国家临床指引也往往会影响设备的选择。同时，欧洲、中东和非洲地区的多个市场对微创治疗和门诊干预的需求日益增长，这导致对注重易用性和可预测结果的设备的需求增加。

亚太地区手术量快速成长、介入治疗能力不断提升以及支付方格局多元化，共同构成了一个复杂却极具发展潜力的环境。该地区各国的监管时间表和区域製造生态系统各不相同，这迫使製造商寻求灵活的商业模式，以兼顾集中式医院网路和快速扩张的门诊医疗机构的需求。总体而言，区域策略必须量身定制，使临床应用驱动因素与监管现实和供应链考量相一致。

竞争格局分析和公司策略凸显了现有企业、挑战者和合作者如何塑造设备组合和伙伴关係关係的未来

血管闭合装置领域的竞争格局呈现一种平衡：现有企业凭藉其临床经验，与新参与企业在技术创新和成本效率方面竞争。现有企业通常受益于与大型医院系统的深厚关係、全面的培训计划以及丰富的上市后监测数据，这些数据为产品的迭代改进提供了资讯。相反，挑战者则经常利用利基市场机会，推出差异化材料、简化的部署机制以及能够证明特定手术方案优越性的有针对性的临床证据。

伙伴关係和策略联盟正变得越来越普遍，器材製造商与契约製造製造商、学术中心和医疗系统合作，以加速临床检验和生产规模扩大。资本配置模式表明，企业更倾向于投资那些能够缩短手术时间或显着降低併发症风险的技术，因为这些成果与医疗系统的品质指标和报销优先事项密切相关。此外，我们持续看到整合和选择性收购的趋势，因为大型公司正在寻求扩大产品系列，并确保在不影响内部开发的情况下获得创新技术。

对製造商而言，在法规合规性、供应链韧性和持续临床参与之间保持平衡至关重要。投资强大的临床医生教育、透明的绩效评估和自适应供应链的公司将能够应对不断变化的采购标准，并抓住流程和医疗服务模式转变带来的机会。

为製造商和相关人员提供实用的优先建议，以加速采用、加强供应链并使证据与医疗保健提供者的优先事项保持一致

为了抓住程序性护理领域的新机会，产业领导者应采取一种将产品创新、临床证据产生和供应链韧性相结合的协作方式。首先，优先考虑设计改进，以降低程序复杂性并提高部署一致性，无论操作员的技能水平如何。改进的可用性和直觉的交付系统降低了培训门槛，并加速了其在门诊和医院环境中的采用。其次，投资于临床证据项目，将设备性能与医疗保健提供者衡量的运作结果（例如止血时间、恢復活动的时间以及术后併发症的减少）明确地结合起来。

同时，我们透过多元化供应商、评估关键零件的近岸外包选项以及协商在关税和贸易不确定性下提供灵活性的合约条款来加强我们的供应链策略。在商业性，我们透过提供差异化的价值提案来客製化我们的上市模式，以满足最终用户的需求。我们强调为医院系统提供培训和服务包，为门诊手术中心提供吞吐量和易用性优势，并在直销不切实际的情况下利用我们的分销商网络覆盖广泛的地区。最后，我们与临床领导者和医疗系统买家建立合作伙伴关係，共同开发证据，部署试验计画，并确保长期采用伙伴关係，以表明对结果的共用课责。

这些措施结合起来可以提高竞争力，减少营运衝击，并增加设备创新产生持久临床和商业性影响的可能性。

结合临床医生访谈、证据综合和数据三角测量的透明调查方法可确保获得可靠、可操作的见解

本摘要所依据的研究结合了对临床医生、采购主管和行业高管的初步研究，以及对监管文件、同行评审临床文献和真实世界资讯来源的严格二次研究。初步研究包括结构化访谈和定性深入对话，旨在揭示临床医生的工作流程限制、培训需求和采购决策驱动因素。这些调查也辅以与卫生系统管理人员的咨询，以明确营运重点和资源分配考量。

二次研究包括对临床研究、操作指南和监管文件的系统性回顾，以检验关于器械安全性和性能的声明。我们运用资料三角测量技术，将访谈所得见解与已发表的结果和器械标籤资讯进行比对，以确保建议反映的是综合证据，而非孤立的轶事。我们谨慎地将独特资讯匿名化，并将经验总结成适用于不同组织情境的通用主题。

品质保证流程包括临床专家的最后覆核、引用的监管文献的检验以及反覆的审查週期，以完善结论。本调查方法强调透明度、可重复性以及与行业最佳实践的一致性，为相关人员提供可靠的策略和营运决策基础。

将临床需求、技术创新和策略行动连结起来的简明综合结论，以实现持续采用和改善结果

总而言之，血管闭合器材领域正面临双重压力：临床对更安全、更快速止血的需求，以及商业性需求对可证明价值的奖励。技术创新正在释放机会，以满足先前未被满足的需求，而医疗服务流程的趋势和变革正在重新定义这些器材的使用方式和场所。能够成功将产品设计与临床医生工作流程、监管要求和弹性供应链相结合的组织，将最有可能将其创新转化为持久的应用。

此外，不断变化的商业环境（包括贸易政策变化、采购整合和区域差异）需要灵活的策略，将可靠的临床证据与灵活的分销和生产方法相结合。透过专注于有针对性的细分市场、严格的结果衡量以及与医疗系统的合作试验，相关人员可以在管理营运风险的同时加速有意义的应用。最终，严谨的、以证据主导的方法对于将技术潜力转化为更好的患者治疗效果和永续的商业性绩效至关重要。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用生物可吸收血管闭合系统来促进患者康復并减少併发症
  • 将即时超音波引导整合到闭合手术中可提高手术的准确性和结果。
  • 对微创和快速止血解决方案的需求正在推动向基于聚合物的封闭装置的转变。
  • 人们对抗菌涂层封闭装置的兴趣日益浓厚，以降低大容量导管插入实验室的感染风险。
  • 不断演变的报销政策和简化的监管途径将如何影响创新 VCD 的市场准入
  • 缝合线和夹子闭合技术之间的竞争日益激烈，影响定价和发展策略

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 血管闭合装置市场（依产品类型）

  • 基于夹子的设备
  • 胶原蛋白塞装置
    • 牛胶原蛋白塞
    • 合成胶原蛋白塞
  • 外部压缩装置
  • 基于密封剂的设备
    • 几丁聚醣密封胶
    • 聚乙二醇密封胶
  • 基于缝合的设备

9. 血管闭合装置市场（依手术类型）

  • 诊断程序
    • 血管造影术
    • 血流动力学监测
  • 干预程序
    • 心血管介入
    • 週边血管介入治疗

第 10 章血管闭合装置市场进入网站

  • 股动脉通路
  • 桡动脉入路

第 11 章血管闭合装置市场（依最终用户）

  • 门诊手术中心
  • 诊所
  • 医院

第 12 章血管闭合装置市场（依通路）

  • 直销
  • 第三方经销商

第十三章血管闭合装置市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第14章血管闭合装置市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章血管闭合装置市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Terumo Corporation
    • Teleflex Incorporated
    • Cardinal Health, Inc.
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Merit Medical Systems, Inc.
    • B. Braun Melsungen AG
    • Cook Medical LLC
    • Lake Region Medical, Inc.
Product Code: MRR-ED54C46E8A80

The Vascular Closure Device Market is projected to grow by USD 3.11 billion at a CAGR of 7.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.71 billion
Estimated Year [2025] USD 1.85 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 7.73%

An authoritative introduction framing clinical priorities, regulatory pressures, and procedural trends that are reshaping vascular closure device choices

The vascular closure device landscape sits at the intersection of clinical need, procedural efficiency, and device innovation. Over the past decade, clinicians and hospital administrators have prioritized solutions that reduce time to hemostasis, lower complication rates, and enable faster patient throughput without compromising procedural safety. Consequently, technology developers have responded with a range of mechanical and biological approaches designed to address distinct access-site challenges while integrating with diverse procedural workflows.

Regulatory pathways, reimbursement pressures, and an increasingly outcomes-driven purchasing environment continue to shape device development and adoption. As institutions seek demonstrable reductions in length of stay and post-procedural complications, clinical evidence and real-world performance data have become decisive factors in procurement decisions. At the same time, procedural trends such as the expansion of radial access and the shift of lower-risk interventions to ambulatory settings are redefining clinical requirements and use cases.

Taken together, these forces create a dynamic environment where incremental improvements in ease of use, safety profile, and compatibility with minimally invasive approaches can yield significant clinical and operational advantages. This introduction establishes the core themes explored throughout the rest of this summary: technological differentiation, procedural alignment, regulatory considerations, and the changing needs of providers and payers.

Key transformative shifts in clinical practice, device innovation, and procurement dynamics that are redefining the vascular closure device landscape

The landscape for vascular closure devices is undergoing several transformative shifts driven by clinical practice evolution, technological refinement, and care-delivery reorganization. First, there is a clear clinical push toward devices that facilitate earlier ambulation and reduce access-site complications, which in turn raises the bar for demonstrable safety and ease of deployment. Clinicians increasingly favor solutions that minimize manual compression time and are compatible with same-day discharge pathways, especially in outpatient or ambulatory settings.

Second, device innovation is migrating from purely mechanical solutions to hybrid and biologically active approaches that aim to accelerate hemostasis while reducing foreign-body reactions. This trend includes refinement of suture-based closure techniques, development of resorbable plugs with optimized biointegration, and sealants formulated to adhere effectively under challenging hemodynamic conditions. Meanwhile, manufacturers are focusing on usability enhancements-ergonomic delivery systems, simplified training workflows, and clear procedural guidance-to reduce variability in clinical outcomes.

Third, the structural dynamics of healthcare procurement are altering market access strategies. Hospital systems and ambulatory surgical centers are consolidating purchasing frameworks and demanding robust real-world evidence and post-market surveillance data. These shifts require manufacturers to develop comprehensive value dossiers that link clinical performance to operational benefits and resource utilization. As a result, strategic collaborations between device companies, clinical leaders, and health systems are becoming an essential pathway to adoption.

How the 2025 United States tariff measures reshaped supply chain strategies, product prioritization, and pricing dynamics across the device value chain

The introduction of United States tariff measures in 2025 has exerted a notable influence across the supply chain, affecting component sourcing, manufacturing strategies, and pricing dynamics for device manufacturers. Tariffs on certain imported materials and subassemblies have prompted companies to reassess supplier footprints, accelerate nearshoring of critical components, and in some cases, redesign supply chains to mitigate exposure to incremental duties. These operational responses have been particularly pronounced for firms that previously relied on single-source imports for precision polymers, biologic feedstocks, or proprietary delivery components.

In parallel, tariff-driven cost pressures have led several manufacturers to re-evaluate product portfolios and prioritize investments in higher-margin, differentiated technologies over commoditized offerings. This shift has implications for competitive positioning, as smaller players with less flexible supply chains face heightened margin compression while larger organizations leverage scale to absorb or offset duty increases. Additionally, procurement teams at health systems are responding to downstream pricing adjustments by conducting more rigorous cost-benefit analyses, emphasizing total cost of care and supplier reliability over unit price alone.

Finally, regulatory and trade uncertainty has prompted a renewed focus on inventory resilience and contractual safeguards. Companies are increasingly negotiating longer-term agreements with suppliers, diversifying vendor bases, and investing in supply chain visibility tools to anticipate and respond to tariff-related disruptions. As a result, the 2025 tariff environment has catalyzed strategic realignment across manufacturing, procurement, and commercial operations.

Segment-driven insights revealing how product design, procedural context, access site dynamics, end-user requirements, and distribution paths shape adoption patterns

A nuanced examination of segmentation reveals where clinical needs intersect with product capabilities and commercial channels. Based on product type, the field includes Clip Based Devices, Collagen Plug Devices, External Compression Devices, Sealant Based Devices, and Suture Based Devices; within collagen plugs, distinctions between Bovine Collagen Plugs and Synthetic Collagen Plugs influence clinician preference based on biocompatibility concerns and resorption profiles, while sealant choices such as Chitosan Sealants and Polyethylene Glycol Sealants reflect trade-offs between adhesive strength and inflammatory potential. These product-level differences affect not only clinical selection but also training requirements and inventory planning.

Turning to procedure type, diagnostic procedures encompass Angiographic Procedures and Hemodynamic Monitoring where rapid hemostasis and minimal interference with vascular imaging are paramount, whereas interventional procedures include Cardiovascular Interventions and Peripheral Vascular Interventions that demand closure reliability under higher anticoagulation or larger-bore sheath scenarios. Access site segmentation-Femoral Access versus Radial Access-continues to be a critical determinant of device relevance, with radial access driving demand for lower-profile, user-friendly systems and femoral access sustaining the need for robust mechanical closure options.

End user distinctions among Ambulatory Surgical Centers, Clinics, and Hospitals shape purchasing behavior and device adoption timelines, as ambulatory settings prioritize throughput and ease of use while hospitals emphasize comprehensive clinical evidence and multi-operator applicability. Distribution channel dynamics split between Direct Sales and Third Party Distributors, with direct sales enabling closer clinical training and value proposition alignment and third party distributors offering breadth and reach across heterogeneous customer bases. Together, these segmentation layers create multiple pathways for targeted product development and differentiated go-to-market strategies.

Regional dynamics and strategic implications across the Americas, Europe, Middle East & Africa, and Asia-Pacific that inform tailored market approaches

Regional dynamics exert a strong influence on clinical preferences, regulatory approaches, and commercial strategies. In the Americas, clinical practice patterns are characterized by broad adoption of both radial and femoral access techniques, progressive reimbursement models that increasingly reward efficiency, and a concentrated group of large integrated health systems that can accelerate adoption of innovations when supported by robust evidence. Supply chain proximity and domestic manufacturing capabilities also play a role in procurement decisions, influencing how companies structure distribution and service models within the region.

In Europe, Middle East & Africa, heterogeneous regulatory environments and a diversity of healthcare delivery settings create both challenges and opportunities for market entrants. Reimbursement mechanisms vary widely across countries, and local clinical guidelines often influence device selection more than multinational promotional efforts. Meanwhile, several EMEA markets show a growing appetite for minimally invasive approaches and outpatient interventions, which in turn drives demand for devices that prioritize ease of use and predictable outcomes.

Across Asia-Pacific, the combination of rapid procedural growth, expanding interventional capabilities, and varied payer landscapes creates a complex but high-potential environment. Countries within the region differ in their regulatory timelines and local manufacturing ecosystems, prompting manufacturers to pursue flexible commercial models that accommodate both centralized hospital networks and rapidly expanding ambulatory providers. Overall, regional strategies must be tailored to align clinical adoption drivers with regulatory realities and supply chain considerations.

Competitive landscape analysis and corporate strategies highlighting how incumbents, challengers, and collaborators are shaping the future of device portfolios and partnerships

Competitive dynamics in the vascular closure device arena are characterized by a balance between established players that leverage clinical legacy and newer entrants that compete on innovation and cost-efficiency. Incumbent firms often benefit from deep relationships with large hospital systems, comprehensive training programs, and extensive post-market surveillance data that inform iterative product improvements. Conversely, challenger companies frequently exploit niche opportunities by introducing differentiated materials, simplified deployment mechanisms, or focused clinical evidence demonstrating specific procedural advantages.

Partnerships and strategic alliances are increasingly common, as device makers collaborate with contract manufacturers, academic centers, and health systems to accelerate clinical validation and scale manufacturing. Capital allocation patterns reveal a preference for funding technologies that reduce procedural time or demonstrably lower complication risks, because these outcomes align closely with health system quality metrics and reimbursement priorities. Additionally, a trend toward consolidation and selective acquisition remains visible, as larger organizations seek to broaden product portfolios and secure access to innovative technologies without internal development lag.

For manufacturers, maintaining a balance between regulatory compliance, supply chain resilience, and continuous clinical engagement is essential. Companies that invest in robust clinician education, transparent performance measurement, and adaptable supply arrangements are better positioned to navigate shifting procurement criteria and to capture opportunities presented by changes in procedural practice and care delivery models.

Practical, prioritized recommendations for manufacturers and stakeholders to accelerate adoption, strengthen supply chains, and align evidence with provider priorities

Industry leaders should pursue a coordinated approach that combines product innovation, clinical evidence generation, and supply chain resilience to capture emerging opportunities in procedural care. First, prioritize design enhancements that reduce procedural complexity and improve deployment consistency across operator skill levels; usability improvements and intuitive delivery systems lower training barriers and accelerate uptake in ambulatory and hospital settings. Second, invest in clinical evidence programs that clearly align device performance with operational outcomes valued by providers, such as time to hemostasis, return-to-activity timelines, and reduced post-procedural complications.

Simultaneously, strengthen supply chain strategies by diversifying supplier bases, assessing nearshoring options for critical components, and negotiating contractual terms that provide flexibility under tariff and trade uncertainties. Commercially, tailor go-to-market models to end-user needs by offering differentiated value propositions: provide training and service bundles for hospital systems, emphasize throughput and ease-of-use benefits for ambulatory surgical centers, and leverage distributor networks for broad geographic reach where direct sales are impractical. Finally, cultivate partnerships with clinical leaders and health system purchasers to co-develop evidence, deploy pilot programs, and secure long-term adoption commitments that demonstrate shared accountability for outcomes.

Taken together, these actions will improve competitiveness, reduce exposure to operational shocks, and increase the likelihood that device innovations translate into sustained clinical and commercial impact.

Transparent research methodology combining clinician interviews, evidence synthesis, and data triangulation to ensure credible, actionable insights

The research underpinning this summary combined primary interviews with clinicians, procurement leaders, and industry executives alongside rigorous secondary review of regulatory filings, peer-reviewed clinical literature, and real-world evidence sources. Primary research consisted of structured interviews and qualitative depth conversations designed to surface clinician workflow constraints, training needs, and procurement decision drivers. These engagements were complemented by advisory consultations with health system administrators to contextualize operational priorities and resource allocation considerations.

Secondary research included systematic review of clinical studies, procedure guidelines, and regulatory documentation to validate claims of device safety and performance. Data triangulation techniques were applied to reconcile insights from interviews with published outcomes and device labeling information, ensuring that recommendations reflect convergent evidence rather than isolated anecdotes. Care was taken to anonymize proprietary information and to synthesize learnings into generalized themes applicable across different organizational contexts.

Quality assurance processes included cross-checks by clinical subject-matter experts, verification of cited regulatory references, and iterative review cycles to refine conclusions. The methodology emphasizes transparency, repeatability, and alignment with industry best practices to provide stakeholders with a credible basis for strategic planning and operational decision-making.

Concise concluding synthesis connecting clinical needs, technological innovation, and strategic actions to achieve durable adoption and improved outcomes

In conclusion, the vascular closure device domain is evolving under the twin pressures of clinical demand for safer, faster hemostasis and commercial imperatives that reward demonstrable value. Technological innovation is unlocking opportunities to address previously unmet needs, while procedural trends and care-delivery shifts are redefining where and how these devices are used. Organizations that successfully align product design with clinician workflows, regulatory expectations, and resilient supply chains will be best positioned to translate innovation into durable adoption.

Moreover, the shifting commercial environment-accentuated by trade policy changes, procurement consolidation, and regional variability-requires flexible strategies that combine robust clinical evidence with adaptive distribution and manufacturing approaches. By focusing on targeted segmentation, rigorous outcome measurement, and collaborative pilots with health systems, stakeholders can accelerate meaningful adoption while managing operational risk. Ultimately, a disciplined, evidence-led approach will be essential for converting technological potential into improved patient outcomes and sustainable commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of bioabsorbable vascular closure systems to enhance patient recovery and reduce complications
  • 5.2. Integration of real-time ultrasound guidance in closure procedures improving procedural accuracy and outcomes
  • 5.3. Shift toward polymer-based closure devices driven by demand for minimally invasive and faster hemostasis solutions
  • 5.4. Growing interest in antimicrobial-coated closure devices to mitigate infection risks in high-volume cath labs
  • 5.5. Impact of evolving reimbursement policies and streamlined regulatory pathways on market entry for innovative VCDs
  • 5.6. Rising competition from suture-mediated versus clip-based closure technologies shaping pricing and development strategies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vascular Closure Device Market, by Product Type

  • 8.1. Clip Based Devices
  • 8.2. Collagen Plug Devices
    • 8.2.1. Bovine Collagen Plugs
    • 8.2.2. Synthetic Collagen Plugs
  • 8.3. External Compression Devices
  • 8.4. Sealant Based Devices
    • 8.4.1. Chitosan Sealants
    • 8.4.2. Polyethylene Glycol Sealants
  • 8.5. Suture Based Devices

9. Vascular Closure Device Market, by Procedure Type

  • 9.1. Diagnostic Procedures
    • 9.1.1. Angiographic Procedures
    • 9.1.2. Hemodynamic Monitoring
  • 9.2. Interventional Procedures
    • 9.2.1. Cardiovascular Interventions
    • 9.2.2. Peripheral Vascular Interventions

10. Vascular Closure Device Market, by Access Site

  • 10.1. Femoral Access
  • 10.2. Radial Access

11. Vascular Closure Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Vascular Closure Device Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Third Party Distributors

13. Vascular Closure Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vascular Closure Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vascular Closure Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Terumo Corporation
    • 16.3.3. Teleflex Incorporated
    • 16.3.4. Cardinal Health, Inc.
    • 16.3.5. Boston Scientific Corporation
    • 16.3.6. Becton, Dickinson and Company
    • 16.3.7. Merit Medical Systems, Inc.
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. Cook Medical LLC
    • 16.3.10. Lake Region Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY BOVINE COLLAGEN PLUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SYNTHETIC COLLAGEN PLUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL COMPRESSION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CHITOSAN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ANGIOGRAPHIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HEMODYNAMIC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR INTERVENTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARK